…
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences. The Global Water segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, primary metals and mining, power generation, global refining, petrochemical, pulp and paper industries. The Global Institutional & Specialty segment provides cleaning and sanitizing products to the foodservice, healthcare, hospitality, lodging, government, education and retail industries. The Global Pest Elimination segment provides pest elimination services to detect, prevent, and eliminate pests comprising rodents and insects in full-service and quick-service restaurants, food and beverage processors, hotels, grocery operations, and other commercial segments, including education, life sciences, and healthcare. The Global Life Sciences segment provides cleaning and contamination control solutions to pharmaceutical and personal care manufacturers. It offers its products under the Ecolab, Kay, Purolite, and Bioquell brand names. The company sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Ecolab supplies water-treatment, hygiene, infection-prevention and cleaning products with related services to industrial, healthcare, foodservice and hospitality customers worldwide. Long-term growth may be supported by stronger regulation and corporate focus on water stewardship and food safety, growth in recurring service contracts and wider adoption of digital water-management tools. Scale, technical expertise and recurring revenue appear to provide resilience across cycles.
Material risks include sensitivity to industrial and hospitality cyclicality, raw-material and energy cost volatility, foreign-exchange and regulatory changes, and execution risks from acquisition integration.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 2547.90M | 2571.20M | 1755.50M | 1343.40M | 1414.20M |
| Minority interest | -17.70M | -19.50M | -20.20M | -17.20M | -14.10M |
| Net income | 2075.60M | 2112.40M | 1372.30M | 1091.70M | 1129.90M |
| Selling general administrative | 4257.90M | 4228.20M | 3948.90M | 3653.80M | 3416.10M |
| Gross profit | 7158.10M | 6843.00M | 6177.20M | 5356.80M | 5117.30M |
| Reconciled depreciation | 976.40M | 935.40M | 929.60M | 938.70M | 843.10M |
| Ebit | 2789.00M | 2909.60M | 2110.20M | 788.80M | 892.00M |
| Ebitda | 3461.60M | 3845.00M | 3033.80M | 1727.50M | 1735.10M |
| Depreciation and amortization | 672.60M | 935.40M | 923.60M | 938.70M | 843.10M |
| Non operating income net other | - | - | - | 24.50M | 33.90M |
| Operating income | 2912.60M | 2612.40M | 2160.70M | 788.80M | 892.00M |
| Other operating expenses | 13168.60M | 13129.00M | 13159.50M | 12484.80M | 11031.90M |
| Interest expense | 241.10M | 338.40M | 354.70M | 243.60M | 218.30M |
| Tax provision | 454.60M | 439.30M | 287.90M | 234.50M | 270.20M |
| Interest income | 241.10M | 57.80M | 31.30M | 243.60M | 185.20M |
| Net interest income | -241.10M | -282.50M | -295.80M | -243.60M | -218.30M |
| Extraordinary items | - | - | - | 0.00M | 0.00M |
| Non recurring | - | - | - | 140.50M | 102.60M |
| Income tax expense | 454.60M | 439.30M | 362.50M | 234.50M | 270.20M |
| Total revenue | 16081.20M | 15741.40M | 15320.20M | 14187.80M | 12733.10M |
| Total operating expenses | 4245.50M | 4230.60M | 4016.50M | 3653.80M | 3416.10M |
| Cost of revenue | 8923.10M | 8898.40M | 9143.00M | 8831.00M | 7615.80M |
| Total other income expense net | -364.70M | -41.20M | -405.20M | 554.60M | 522.20M |
| Net income from continuing ops | 2093.30M | 2131.90M | 1251.70M | 1108.90M | 1144.00M |
| Net income applicable to common shares | 2075.60M | 2112.40M | 1372.30M | 1091.70M | 1129.90M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 24696.30M | 22387.80M | 21846.60M | 21464.30M | 21206.40M |
| Intangible assets | 3688.50M | 3308.80M | 3493.50M | 3680.70M | 4224.10M |
| Other current assets | 569.60M | 275.70M | 206.30M | 404.70M | 357.00M |
| Total liab | 14891.80M | 13598.60M | 13774.40M | 14205.70M | 13953.30M |
| Total stockholder equity | 9770.80M | 8757.30M | 8044.70M | 7236.10M | 7224.20M |
| Deferred long term liab | - | - | - | 505.60M | 622.00M |
| Other current liab | 2459.00M | 2122.80M | 1753.40M | 1860.60M | 1666.30M |
| Common stock | 369.40M | 367.80M | 365.70M | 364.70M | 364.10M |
| Capital stock | 369.40M | 367.80M | 365.70M | 364.70M | 364.10M |
| Retained earnings | 12834.00M | 11517.10M | 10075.40M | 9318.80M | 8814.50M |
| Other liab | - | - | - | 1582.20M | 1770.30M |
| Good will | 9227.00M | 7907.30M | 8148.20M | 8012.70M | 8063.90M |
| Other assets | 782.70M | 670.40M | 0.00M | 535.10M | 546.00M |
| Cash | 646.20M | 1256.80M | 919.50M | 598.60M | 359.90M |
| Cash and equivalents | 646.20M | 1256.80M | 919.50M | 598.60M | 359.90M |
| Total current liabilities | 5534.70M | 4792.80M | 4345.80M | 4210.40M | 3553.20M |
| Current deferred revenue | - | 102.00M | 110.90M | 116.50M | 91.70M |
| Net debt | 8783.10M | 7025.90M | 7813.90M | 8319.60M | 8680.90M |
| Short term debt | 870.40M | 758.00M | 756.50M | 505.10M | 411.00M |
| Short long term debt | 870.40M | 615.70M | 630.40M | 505.10M | 411.00M |
| Short long term debt total | 9429.30M | 8282.70M | 8733.40M | 8918.20M | 9040.80M |
| Other stockholder equity | -1558.30M | -1145.60M | -546.00M | -720.80M | -319.60M |
| Property plant equipment | 5042.50M | 4475.60M | 4028.10M | 3741.60M | 3685.30M |
| Total current assets | 5955.60M | 6025.70M | 5644.10M | 5494.20M | 4687.10M |
| Net tangible assets | - | - | - | -4457.30M | -5063.80M |
| Net receivables | 3249.40M | 3028.30M | 3021.10M | 2698.10M | 2478.40M |
| Long term debt | 7365.90M | 6949.20M | 7551.40M | 8075.30M | 8347.20M |
| Inventory | 1490.40M | 1464.90M | 1497.20M | 1792.80M | 1491.80M |
| Accounts payable | 2071.00M | 1810.00M | 1566.30M | 1728.20M | 1384.20M |
| Noncontrolling interest in consolidated entity | - | - | - | 22.50M | 28.90M |
| Accumulated other comprehensive income | -1874.30M | -1982.00M | -1850.40M | -1726.60M | -1634.80M |
| Common stock total equity | - | - | - | 364.70M | 364.10M |
| Retained earnings total equity | - | - | - | 9318.80M | 8814.50M |
| Treasury stock | - | - | - | -7301.00M | -6784.20M |
| Non currrent assets other | 782.70M | 469.80M | 389.80M | 427.00M | 546.00M |
| Non current assets total | 18740.70M | 16362.10M | 16202.50M | 15970.10M | 16519.30M |
| Capital lease obligations | 761.20M | 717.80M | 551.60M | 337.80M | 282.60M |
| Long term debt total | 7365.90M | 6949.20M | 7551.40M | 8075.30M | 8347.20M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -433.80M | -852.50M | -716.80M | -4579.70M |
| Change to liabilities | - | - | - | 724.00M | 344.70M |
| Total cashflows from investing activities | -2707.20M | -433.80M | -990.50M | -716.80M | -4579.70M |
| Net borrowings | 469.60M | -628.50M | -501.90M | 89.70M | 2121.30M |
| Total cash from financing activities | -853.30M | -2024.10M | -1054.70M | -837.30M | 1603.20M |
| Change to operating activities | - | - | - | 51.10M | 51.40M |
| Net income | 2093.30M | 2131.90M | 1372.30M | 1108.90M | 1144.00M |
| Change in cash | -610.60M | 337.30M | 320.90M | 238.70M | -900.30M |
| Begin period cash flow | 1256.80M | 919.50M | 598.60M | 359.90M | 1260.20M |
| End period cash flow | 646.20M | 1256.80M | 919.50M | 598.60M | 359.90M |
| Total cash from operating activities | 2952.60M | 2813.90M | 2411.80M | 1788.40M | 2061.90M |
| Depreciation | 672.60M | 935.40M | 923.60M | 938.70M | 843.10M |
| Other cashflows from investing activities | -37.60M | -16.10M | -35.30M | -4.00M | -3936.70M |
| Dividends paid | 753.60M | 664.30M | 617.30M | -602.80M | -566.40M |
| Change to inventory | 36.40M | -115.60M | 320.30M | -402.90M | -73.00M |
| Change to account receivables | -185.90M | -146.70M | -84.30M | -319.60M | -178.20M |
| Sale purchase of stock | -783.80M | -986.50M | -13.70M | -518.20M | -106.60M |
| Other cashflows from financing activities | -13.70M | 255.20M | 78.20M | 283.70M | 11.40M |
| Change to netincome | - | - | - | 17.50M | 74.20M |
| Capital expenditures | 1048.30M | 994.50M | 774.80M | 712.80M | 643.00M |
| Change receivables | - | - | - | -319.60M | -178.20M |
| Cash flows other operating | - | - | - | 830.70M | -92.90M |
| Cash and cash equivalents changes | - | - | - | 234.30M | -914.60M |
| Change in working capital | -206.20M | 176.10M | 162.70M | -276.70M | 0.60M |
| Stock based compensation | 136.60M | 134.80M | 95.10M | 87.80M | 89.50M |
| Other non cash items | 289.70M | -373.80M | -86.20M | 72.30M | -14.20M |
| Free cash flow | 1904.30M | 1819.40M | 1637.00M | 1075.60M | 1418.90M |
Sector: Basic Materials Industry: Specialty Chemicals
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ECL Ecolab Inc |
2.97 0.97% |
307.65 | 37.06 | 29.59 | 4.57 | 7.68 | 5.11 | 21.59 |
| LIN Linde plc Ordinary Shares |
5.68 1.11% |
517.24 | 33.77 | 28.90 | 6.56 | 5.42 | 7.03 | 18.92 |
| AIQUY Air Liquide SA ADR |
1.19 2.92% |
41.94 | 30.69 | 24.81 | 4.70 | 4.10 | 4.36 | 15.61 |
| AIQUF L'Air Liquide S.A |
3.63 1.82% |
203.13 | 29.78 | 22.68 | 4.54 | 3.98 | 4.50 | 15.90 |
| SHW Sherwin-Williams Co |
16.24 4.76% |
357.11 | 33.33 | 27.40 | 3.38 | 20.60 | 3.88 | 21.36 |
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences. The Global Water segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, primary metals and mining, power generation, global refining, petrochemical, pulp and paper industries. The Global Institutional & Specialty segment provides cleaning and sanitizing products to the foodservice, healthcare, hospitality, lodging, government, education and retail industries. The Global Pest Elimination segment provides pest elimination services to detect, prevent, and eliminate pests comprising rodents and insects in full-service and quick-service restaurants, food and beverage processors, hotels, grocery operations, and other commercial segments, including education, life sciences, and healthcare. The Global Life Sciences segment provides cleaning and contamination control solutions to pharmaceutical and personal care manufacturers. It offers its products under the Ecolab, Kay, Purolite, and Bioquell brand names. The company sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.
| Name | Title | Year Born |
|---|---|---|
| Mr. Christophe Beck | CEO & Chairman | 1968 |
| Mr. Daniel J. Schmechel | Exec. Officer | 1960 |
| Mr. Timothy P. Mulhere | Exec. VP and Pres of Global Institutional & Specialty Services | 1963 |
| Ms. Angela M. Busch | Exec. VP of Corp. Strategy & Bus. Devel. | 1967 |
| Mr. Darrell R. Brown | Pres & COO | 1964 |
| Mr. Scott D. Kirkland | Chief Financial Officer | 1974 |
| Ms. Jennifer J. Bradway | Sr. VP, Corp. Controller & Principal Accounting Officer | 1977 |
| Dr. Larry L. Berger | Exec. VP & CTO | 1961 |
| Mr. David Bingenheimer | Exec. VP & Chief Information Officer | NA |
| Mr. Andrew Hedberg | Director of Investor Relations | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.